27 results
8-K
EX-99.1
RNAC
Cartesian Therapeutics Inc
13 Nov 23
Entry into a Material Definitive Agreement
9:02am
gravis (MG) patients in Phase 2a study Integrated Capabilities Merger to create fully integrated organization with in-house cGMP manufacturing, R&D, regulatory … an engineered cell therapy to treat autoimmunity In-House Manufacturing and R&D Wholly-owned, state-of-the-art GMP manufacturing Designed to optimize processes
8-K
o4ity3
13 May 21
Selecta Biosciences Reports First Quarter 2021 Financial Results and Provides Business Update
8:01am
8-K
EX-99.1
6bjw mvc7dvucg77lf
13 May 21
Selecta Biosciences Reports First Quarter 2021 Financial Results and Provides Business Update
8:01am